These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8432460)

  • 21. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing.
    Verne JE; Aubrey R; Love SB; Talbot IC; Northover JM
    BMJ; 1998 Jul; 317(7152):182-5. PubMed ID: 9665902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
    Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
    Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.
    Jørgensen OD; Kronborg O; Fenger C
    Gut; 2002 Jan; 50(1):29-32. PubMed ID: 11772963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for colorectal cancer, 1996.
    Macrae FA
    Med J Aust; 1996 Jul; 165(2):102-5. PubMed ID: 8692052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
    Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
    Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening for colorectal cancer in Italy, 2010 survey].
    Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevention and early detection of colorectal carcinoma by endoscopic examinations].
    Porschen R; Schmiegel W
    Z Gastroenterol; 1998 May; 36(5):403-14. PubMed ID: 9654708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A screening clinic for relatives of patients with colorectal cancer in a district general hospital.
    Carpenter S; Broughton M; Marks CG
    Gut; 1995 Jan; 36(1):90-2. PubMed ID: 7890243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Objectives and means of screening of colorectal cancer].
    Gignoux M; Valla A; Launoy G; Herbert C
    Rev Prat; 1994 Dec; 44(20):2700-5. PubMed ID: 7878359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
    Prince M; Lester L; Chiniwala R; Berger B
    World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.
    Quintero E; Carrillo M; Leoz ML; Cubiella J; Gargallo C; Lanas A; Bujanda L; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Morillas JD; Balaguer F; Muriel A;
    PLoS Med; 2016 May; 13(5):e1002008. PubMed ID: 27138769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer: risk factors and recommendations for early detection.
    Read TE; Kodner IJ
    Am Fam Physician; 1999 Jun; 59(11):3083-92. PubMed ID: 10392591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility study of colonoscopy as the primary screening investigation in relatives of patients with colorectal cancer.
    Gilbert JM; Vaizey CJ; Cassell PG; Holden J
    Ann R Coll Surg Engl; 2001 Nov; 83(6):415-9. PubMed ID: 11777138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.